Review




Structured Review

ProMIS Neurosciences cognitive function melas short form

Cognitive Function Melas Short Form, supplied by ProMIS Neurosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cognitive function melas short form/product/ProMIS Neurosciences
Average 90 stars, based on 1 article reviews
cognitive function melas short form - by Bioz Stars, 2026-05
90/100 stars

Images

1) Product Images from "27th Annual Conference of the United Mitochondrial Disease Foundation Abstracts - Mitochondrial Medicine 2024 - Cleveland, Ohio – June 26-29, 2024"

Article Title: 27th Annual Conference of the United Mitochondrial Disease Foundation Abstracts - Mitochondrial Medicine 2024 - Cleveland, Ohio – June 26-29, 2024

Journal: Therapeutic Advances in Rare Disease

doi: 10.1177/26330040241276322


Figure Legend Snippet:

Techniques Used: Variant Assay, Activation Assay, Selection, Mutagenesis, CRISPR, Generated, Inhibition, Knock-Out, Sequencing, In Vivo, Derivative Assay, Sterility, Activity Assay, Virus, Diagnostic Assay, Next-Generation Sequencing, Biomarker Assay, Animal Model, Comparison



Similar Products

90
ProMIS Neurosciences cognitive function melas short form

Cognitive Function Melas Short Form, supplied by ProMIS Neurosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cognitive function melas short form/product/ProMIS Neurosciences
Average 90 stars, based on 1 article reviews
cognitive function melas short form - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

Image Search Results


Journal: Therapeutic Advances in Rare Disease

Article Title: 27th Annual Conference of the United Mitochondrial Disease Foundation Abstracts - Mitochondrial Medicine 2024 - Cleveland, Ohio – June 26-29, 2024

doi: 10.1177/26330040241276322

Figure Lengend Snippet:

Article Snippet: The goals of this qualitative study were to 1) identify the key signs, symptoms, and impacts of MELAS from patient and therapeutic-area clinical expert perspectives; 2) evaluate the Patient-Reported Outcomes Measurement Information System (PROMIS®) Fatigue Mitochondrial Disease Short Form and the draft PROMIS Cognitive Function MELAS Short Form for use in adult MELAS patients; and 3) compare the content assessed by the PROMIS questionnaires and performance outcomes measures (PerfOs; 30 Second Sit-to-Stand and tests of cognitive functioning) to clinician- and patient-reported signs, symptoms, and impacts.

Techniques: Variant Assay, Activation Assay, Selection, Mutagenesis, CRISPR, Generated, Inhibition, Knock-Out, Sequencing, In Vivo, Derivative Assay, Sterility, Activity Assay, Virus, Diagnostic Assay, Next-Generation Sequencing, Biomarker Assay, Animal Model, Comparison